11 April 2020 in Clinical Genetics
Nonsyndromic hearing loss is an extremely heterogeneous disorder. Thus, clinical diagnostics is challenging, in particular due to differences in the etiology of hearing loss between populations. With this study, we wanted to elucidate the genetic basis of hearing loss in 61 consanguineous Egyptian families. In 25 families, linkage analysis was used as a prescreening to identify regions for targeted sequencing of candidate genes. Initially, the coding regions of 12 and later of 94 genes associated with hearing loss were enriched and subjected to massively parallel sequencing (MPS) with diagnostic yields of 36% and 75%, respectively. Causative variants were identified in 48 families (79%). They were found in 23 different genes with the majority being located in MYO15A (15.3%), SLC26A4 (9.7%), GJB2 (8.3%), and MYO7A (6.4%). As many as 32 variants were novel ones at the time of detection. Five variants were shared by two, three, or even four families. Our study provides a first survey of the mutational spectrum of deaf patients in Egypt revealing less GJB2 variants than in many European populations. It underlines the value of targeted enrichment of well‐selected deafness genes in combination with MPS in the diagnostics of this frequent and genetically heterogeneous disorder.
7 March 2022 in The Egyptian Journal of Otolaryngology
Background: Early detection of congenital hearing loss (HL) and appropriate intervention is essential to minimize its dramatic impact. Target-based newborn hearing screening (TNHS) was initially targeted high-risk register (HRR) newborn. The advance techniques in neonatology in neonatal intensive care unit (NICU) lead to decrease mortality among low birth weight and preterm infants, but significant morbidities including hearing loss persist. In this study, we aimed to assess the prevalence of hearing loss and the percentage of different risk factors among the HRR neonates admitted to NICU at Assiut University Hospital. Results: The prevalence of hearing loss among the study group is 1%. The most common risk factor present between the study group was prematurity associated with the low birth weight (57%). The combination of preterm and low birth weight has statistically significant effect on hearing loss (p < 0.006). There was statistically significant difference in the pass rate of the transient evoked otoacoustic emission (TEOAE) frequencies included in the screening program. The highest pass rate 91% and 85% was at 4 KH and 3 KH, respectively, while the least pass rate was at 1 KH (11.5%). Conclusion: TEOAE screener is safe, noninvasive, and doesn’t require sedation and cost-effective method in the newborn hearing screening at NICU. For HRR, it is better to do screening before hospital discharge so allowing enough time for comorbidities of the neonate to improve. Neonatal hearing screening in high-risk neonates in NICU allows early identification of children with hearing loss with early intervention.
17 January 2025 in European Archives of Oto-Rhino-Laryngology
EREnas Mostafa O. Ramadan
AEAmira Mohammad Eloseily
Background: Subjective tinnitus is characterized by perception of sound in the absence of any external or internal acoustic stimuli. Many approaches have been developed over the years to treat tinnitus (medical and nonmedical). However, no consensus has been reached on the optimal therapeutic approach. Electrical nerve stimulation targeting peripheral auditory pathways presents a promising area of investigation for the treatment of tinnitus. Non-invasive transcutaneous vagal nerve stimulation of the auricular branch of the vagus nerve has been introduced and studied but its success rate varies and conflicting results have been reported. In this study we aim to assess the role of transcutaneous electrical nerve stimulation in alleviation of tinnitus in normal hearing subjects and to study the different factors that may affect the degree of alleviation of tinnitus. Methods: The study group consisted of 64 subjects (38 male and 26 female). The age ranged between 20 and 60 years. All of them suffering from subjective tinnitus. Assessment of tinnitus loudness analyzed by Visual Analogue Scale (VAS) which was applied before and directly after TENS stimulation. Results: There is a statistically significant difference in tinnitus loudness before and after TEN stimulation as assessed by VAS. 45 out of 64 (70.31%) patients had improvement after TENS, from them nine patients had a complete reduction of tinnitus. There is no statistically significant relation between the studied variables and the degree of tinnitus reduction. Conclusion: ta-VNS is an effective treatment of subjective tinnitus but we could not assess for how long this residual inhibition persists due to lack of long term follow up. However, it is difficult to decide who might benefit from ta-VNS, patients with unilateral tinnitus on right ear and those with whistling sound have more reduction in tinnitus loudness than others.
5 May 2025 in The Egyptian Journal of Otolaryngology
AEAmira Mohammad Eloseily
Purpose: Assess the effect of migraine on different central auditory and cognitive abilities, compare the findings in migraine with aura versus without aura, and during the headache phase of the attack versus interictally. Also, assess if migraine attacks’ frequency and severity affect central auditory and cognitive abilities. Methods: A total of 122 subjects, classified according to the affection with migraine into study group (n = 60) and control group (n = 62). Each participant was subjected to detailed medical history, Migraine Disability Assessment and Headache impact test questionnaires, neurological evaluation, basic audiological evaluation, central auditory function tests (SPIN, DDT, DPT, AFT-R), and cognitive function test (P300). Results: The results showed significant lower performance in all performed central auditory tests in migraine patients compared with controls. In addition, highly significantly lower performance was found among migraineurs in attacks compared with those not in attack. Regarding cognitive function, patients with migraine had significantly longer P300 latency in both ears compared with the control group, but no significant difference in amplitude. it was also found that patients who were in the attack had significantly prolonged P300 latency either at the right or left ear compared to those who were not in attack. Conclusion: Patients with migraine have significantly lower central auditory performance, which is affected by the disease duration, severity, and the presence of migraine attack. They also have significantly prolonged cognitive potential P300 latency not affected by disorder duration or severity but affected by the presence of migraine attack.
6 April 2026 in European Archives of Oto-Rhino-Laryngology
Background: Ménière’s disease (MD) is characterized by episodic vertigo, fluctuating sensorineural hearing loss (SNHL), tinnitus, and aural fullness, with endolymphatic hydrops (EH) considered its key pathological substrate. Despite advances in EH assessment (magnetic resonance imaging [MRI]-based grading and physiologic tests), the strength and consistency of associations between EH severity and audio-vestibular measures remain uncertain. This study aimed to review systematically and meta-analyze correlation coefficients quantifying the relationship between EH severity and audiometric and vestibular measures in adults with MD. Methods: From inception through September 2025, we searched PubMed, Scopus, Web of Science, and Cochrane for publications associating EH with audio-vestibular outcomes in patients with MD. We independently screened and abstracted relevant data, then assessed bias using National Institutes of Health (NIH) tools. Correlations were Fisher Z-transformed and combined using random-effects models. Heterogeneity (I², τ²) and subgroups (cochlear/vestibular and frequency) were assessed. Results: Sixteen studies were included. EH severity showed a moderate correlation with poorer hearing with pure-tone audiometry (PTA): cochlear r = 0.41 (95% CI 0.34–0.48; I²=0%) and vestibular r = 0.42 (0.33–0.51; I²=30.9%). Caloric canal paresis (CP%) correlated weakly (cochlear r = 0.14 [0.01–0.26]; vestibular r = 0.22 [0.10–0.34]; both I²=0%). Clinical stage correlated weak–moderately (cochlear r = 0.33 [0.22–0.43; I²=27.8%]; vestibular r = 0.36 [0.22–0.49; I²=38.4%]). Frequency-specific PTA associations were strongest at low/mid bands (cochlear r = 0.49/0.45; vestibular r = 0.51/0.42) and weaker at high frequencies (cochlear r = 0.30; vestibular r = 0.34). Disease duration showed weak correlations (cochlear r = 0.20 [I²=0%]; vestibular r = 0.33 [I²=30.2%]). Conclusions: The EH severity grades demonstrate moderate correlation with poorer hearing and weak correlation with caloric paresis, and clinical stage shows weak-moderate correlation. Relations are strongest at low and mid frequencies and are more consistent for cochlear than vestibular EH. These observations support EH as an imaging correlate of auditory involvement in MD, particularly for low- and mid-frequency hearing thresholds. However, correlations do not establish causality, and standardized imaging with longitudinal designs is needed to clarify temporal relationships and prognostic utility.
18 March 2025 in European Archives of Oto-Rhino-Laryngology
Objectives: We aimed to analyze auditory involvement in patients with Behcet’s disease and its association with Optical Coherence Tomography Angiography findings and disease manifestations. Methods: This study included 54 eyes and 68 ears of 34 adults with Behcet’s disease in comparison to 30 eyes and 60 ears of healthy controls. Clinical, laboratory and ophthalmological evaluation including Optical Coherence Tomography Angiography was done. Audiological assessment included otoscopic examination, immitancemetry and pure tone and speech audiometry. Results: Sensorineural hearing loss was observed in 32.35% of the studied cases. Behcet’s disease patients showed significantly higher average hearing level and significant reduction of retinal vessel density compared to controls. Patients with sensorineural hearing loss demonstrated significantly lower central retinal capillary vessel density and higher neuro-Behcet’s disease incidence in comparison to those without hearing loss (p-value = 0.039 and 0.024, respectively), which was confirmed by univariate regression analysis. After entering significant factors into the multivariate model, neuro-BD was identified as the most significant single predictor of sensorineural hearing loss in BD (p-value = 0.003). Conclusions: The association between sensorineural hearing loss and central retinal vessel density reduction and neuro- Behcet’s disease should be considered in Behcet’s disease.